Featured publications
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
November 2, 2023 | The New England Journal of Medicine
Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development
April 5, 2023 | Frontiers in Molecular Biosciences
Quantifying the nativeness of antibody sequences using long short-term memory networks
December 31, 2019 | Protein Engineering, Design, and Selection
Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks
March 5, 2016 | EBioMedicine
A broadly neutralizing human monoclonal antibody is effective against H7N9.
August 7, 2015 | PNAS
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.
July 30, 2015 | Cell
Antibody-Based Strategies to Prevent and Treat Influenza.
July 13, 2015 | Frontiers in Immunology
Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization.
April 11, 2015 | Current Opinion in Virology
Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity.
June 20, 2013 | Cell
Glycan receptor binding of the influenza A virus H7N9 hemagglutinin.
June 6, 2013 | Cell
Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.
May 22, 2013 | Virus Research
Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin.
April 23, 2013 | PLoS One
Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic.
April 23, 2013 | PLoS One